DJIA 18,065.57 -137.80 -0.76%
NASDAQ 4,947.45 -32.46 -0.65%
S&P 500 2,092.36 -15.42 -0.73%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

57.89 -0.45 (-0.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $57.89 -0.77%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.41
Previous Close $58.34
Daily Range $57.98 - $58.55
52-Week Range $52.49 - $63.62
Market Cap $164.3B
P/E Ratio 14.33
Dividend (Yield) $1.80 (3.1%)
Ex-Dividend Date
Dividend Pay Date
03/12/15
04/08/15
Volume 1,258,836
Average Daily Volume 9,963,056
Current FY EPS $3.42

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

Bristol-Myers Squibb’s $1.6 Billion On New Drug Deals Is Well Spent

Merck’s Partnership With NGM Is A Bold Move

Fast Money Picks For March 2

This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed

Intrexon, led by biotech billionaire R.J. Kirk, acquired a little known Belgian biotech. Is it a big deal for investors?

Which Cancer Immunotherapy Will Be the Most Successful?

Motley Fool experts discuss whether Bristol-Myers Squibb's Opdivo or Merck & Co.'s Keytruda will be the bigger commercial success.

Bayer Q4 Net Income Down Y/Y, Provides 2015 Outlook - Analyst Blog

Dow Jones (DJIA) Today: Merck (MRK) Lower

Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers

Noteworthy ETF Inflows: IYH, MRK, GILD, AMGN

See More MRK News...

MRK's Top Competitors

MRK $57.89 (-0.77%)
Current stock: MRK
JNJ $101.21 (-1.10%)
Current stock: JNJ
NVS $98.08 (-0.99%)
Current stock: NVS
RHHBY $32.99 (-1.41%)
Current stock: RHHBY